Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 928485, 7 pages
http://dx.doi.org/10.1155/2013/928485
Research Article

Overexpression of Regulatory T Cells Type 1 (Tr1) Specific Markers in a Patient with HCV-Induced Hepatocellular Carcinoma

1CNRS UMR 8161, Institut de Biologie de Lille, 1 rue du Professeur Calmette, 59021 Lille Cedex, France
2UPMC Université Paris 6, Inserm, UMR-S938, Centre de Recherche Saint Antoine, 75012 Paris, France
3Service de Chirurgie Digestive et Transplantations, Hôpital Huriez, CHU, Université Nord-de-France, 59000 Lille, France
4Centre de Transplantation Hépatique, Pôle Digestif, APHP, Hôpital Saint Antoine, 184 rue de Faubourg Saint Antoine, 75012 Paris, France

Received 27 June 2013; Accepted 24 July 2013

Academic Editors: D. Capone, A. Castiella, and O. Topcu

Copyright © 2013 Laurissa Ouaguia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Alter, H. S. Margolis, K. Krawczynski et al., “The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B Hepatitis Study Team,” The New England Journal of Medicine, vol. 31, pp. 1899–1905, 1992. View at Google Scholar
  2. K.-M. Chang, R. Thimme, J. J. Melpolder et al., “Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection,” Hepatology, vol. 33, no. 1, pp. 267–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Rehermann, “Cell mediated immune response to the hepatitis C virus,” Current Topics in Microbiology and Immunology, vol. 242, pp. 299–325, 2000. View at Google Scholar · View at Scopus
  4. S.-L. Tsai, Y.-F. Liaw, M.-H. Chen, C.-Y. Huang, and G. C. Kuo, “Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity,” Hepatology, vol. 25, no. 2, pp. 449–458, 1997. View at Google Scholar · View at Scopus
  5. S. Kakumu, A. Okumura, T. Ishikawa, K. Iwata, M. Yano, and K. Yoshioka, “Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection,” Clinical and Experimental Immunology, vol. 108, no. 1, pp. 138–143, 1997. View at Google Scholar · View at Scopus
  6. R. P. Woitas, U. Petersen, D. Moshage et al., “HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C,” World Journal of Gastroenterology, vol. 8, no. 3, pp. 562–566, 2002. View at Google Scholar · View at Scopus
  7. H. Groux, M. Bigler, J. E. de Vries, and M.-G. Roncarolo, “Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells,” Journal of Experimental Medicine, vol. 184, no. 1, pp. 19–29, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Groux, A. O'Garra, M. Bigler et al., “A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature, vol. 389, no. 6652, pp. 737–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. P. McGuirk, C. McCann, and K. H. G. Mills, “Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis,” Journal of Experimental Medicine, vol. 195, no. 2, pp. 221–231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Xu, K. Sumita, C. Feng et al., “Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice,” Journal of Immunology, vol. 167, no. 1, pp. 235–241, 2001. View at Google Scholar · View at Scopus
  11. M. Rahmoun, A. Foussat, H. Groux, J. Pène, H. Yssel, and P. Chanez, “Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity,” International Archives of Allergy and Immunology, vol. 140, no. 2, pp. 139–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Cabrera, Z. Tu, Y. Xu et al., “An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection,” Hepatology, vol. 40, no. 5, pp. 1062–1071, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Rushbrook, S. M. Ward, E. Unitt et al., “Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7852–7859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Boettler, H. C. Spangenberg, C. Neumann-Haefelin et al., “T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7860–7867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Manigold and V. Racanelli, “T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies,” Lancet Infectious Diseases, vol. 7, no. 12, pp. 804–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Carpentier, F. Conti, F. Stenard et al., “Increased expression of regulatory tr1 cells in recurrent hepatitis C after liver transplantation,” American Journal of Transplantation, vol. 9, no. 9, pp. 2102–2112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Ni, E. Hembrador, A. M. Di Bisceglie et al., “Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients,” Journal of Immunology, vol. 170, no. 6, pp. 3429–3439, 2003. View at Google Scholar · View at Scopus
  18. M. P. Curry, L. Golden-Mason, D. G. Doherty et al., “Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver,” Journal of Hepatology, vol. 38, no. 5, pp. 642–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Leroy, I. Vigan, J.-F. Mosnier et al., “Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C,” Hepatology, vol. 38, no. 4, pp. 829–841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bergamini, F. Bolacchi, G. Cerasari et al., “Lack of evidence for the Th2 predominance in patients with chronic hepatitis C,” Clinical and Experimental Immunology, vol. 123, no. 3, pp. 451–458, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ulsenheimer, J. T. Gerlach, N. H. Gruener et al., “Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C,” Hepatology, vol. 37, no. 5, pp. 1189–1198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Tarantino, A. Coppola, P. Conca, E. Cimino, and G. di Minno, “Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis?” International Journal of Immunopathology and Pharmacology, vol. 21, no. 4, pp. 1007–1012, 2008. View at Google Scholar · View at Scopus
  23. N. Delhem, F. Cottrez, A. Carpentier et al., “Role of the regulatory T lymphocytes in hepatitis C fibrosis progression,” Bulletin du Cancer, vol. 95, no. 11, pp. 1029–1038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. MacDonald, M. Duffy, M. T. Brady et al., “CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons,” Journal of Infectious Diseases, vol. 185, no. 6, pp. 720–727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Sugimoto, F. Ikeda, J. Stadanlick, F. A. Nunes, H. J. Alter, and K.-M. Chang, “Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection,” Hepatology, vol. 38, no. 6, pp. 1437–1448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kuzushita, N. Hayashi, K. Katayama et al., “High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C,” Scandinavian Journal of Gastroenterology, vol. 32, no. 2, pp. 169–174, 1997. View at Google Scholar · View at Scopus
  27. G. Tarantino, P. Conca, M. Tarantino et al., “Does spleen volume play a role in patients with HCV-related chronic hepatitis?” International Journal of Immunopathology and Pharmacology, vol. 22, no. 4, pp. 1009–1017, 2009. View at Google Scholar · View at Scopus